Literature DB >> 30644586

Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations.

Gretchen L Sacha1, Seth R Bauer1, Ishaq Lat2.   

Abstract

Septic shock is a life-threatening disorder associated with high mortality rates requiring rapid identification and intervention. Vasoactive agents are often required to maintain goal hemodynamics and preserve tissue perfusion. However, guidance regarding the proper administration of adjunct agents for the management of septic shock is limited in patients who are refractory to norepinephrine. This review summarizes vasopressor agents and describes the nuanced application of these agents in patients with septic shock, specifically focusing on clinical scenarios with limited guidance including patients who are nonresponsive to first-line agents and individuals with mixed shock states, tachyarrhythmias, obesity, valvular abnormalities, or other comorbid conditions.
© 2019 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  angiotensin II; epinephrine; norepinephrine; phenylephrine; sepsis; septic shock; vasoactive agents; vasopressin

Mesh:

Substances:

Year:  2019        PMID: 30644586     DOI: 10.1002/phar.2220

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

Review 1.  Timing of vasoactive agents and corticosteroid initiation in septic shock.

Authors:  Mahmoud A Ammar; Abdalla A Ammar; Patrick M Wieruszewski; Brittany D Bissell; Micah T Long; Lauren Albert; Ashish K Khanna; Gretchen L Sacha
Journal:  Ann Intensive Care       Date:  2022-05-30       Impact factor: 10.318

Review 2.  Polymers and Plastics Modified Electrodes for Biosensors: A Review.

Authors:  Sonia Lanzalaco; Brenda G Molina
Journal:  Molecules       Date:  2020-05-24       Impact factor: 4.411

3.  Angiotensin II-mediated improvement of renal mitochondrial function via the AMPK/PGC-1α/NRF-2 pathway is superior to norepinephrine in a rat model of septic shock associated with acute renal injury.

Authors:  Hui An; Zhenjie Hu; Yuhong Chen; Lianfang Cheng; Jian Shi; Linan Han
Journal:  Ann Transl Med       Date:  2021-03

4.  The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.

Authors:  Richard G W Proudman; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2021-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.